Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison

Belal Firwana, Mohamad Bassam Sonbol, Maria Diab, Shahzad Raza, Rim Hasan, Ibrahim Yousef, Ahmad Zarzour, Archana Garipalli, Donald Doll, M. Hassan Murad, Aref Al-Kali

Research output: Contribution to journalArticle

12 Scopus citations

Fingerprint Dive into the research topics of 'Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison'. Together they form a unique fingerprint.

Medicine & Life Sciences